Clinical Trial Update: Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Ferrlecit (ferric gluconate) maintenance dosing in hemodialysis patients studying efficacy and safety; trial terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• FERRLECIT (SODIUM FERRIC GLUCONATE COMPLEX)

Snippet

Sponsor: Sanofi | Conditions: Anemia | Phase 4 | Status: TERMINATED